Hong Kong Pharma Digital Technology Holdings ROE 1970-1969 | HKPD

Current and historical return on equity (ROE) values for Hong Kong Pharma Digital Technology Holdings (HKPD) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Hong Kong Pharma Digital Technology Holdings ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
Sector Industry Market Cap Revenue
$0.019B $0.000B
Hong Kong Pharma Digital Technology Holdings Limited is a provider of over the counter pharmaceutical cross-border e-commerce supply chain services principally in Hong Kong. Hong Kong Pharma Digital Technology Holdings Limited is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Oaktree Acquisition III Life Sciences (OACC) United States $0.224B 0.00
PicoCELA (PCLA) Japan $0.173B 0.00
Aduro Clean Technologies (ADUR) Canada $0.156B 0.00
Range Capital Acquisition (RANG) United States $0.140B 0.00
Tavia Acquisition (TAVI) $0.139B 0.00
CO2 Energy Transition (NOEM) $0.095B 0.00
Leishen Energy Holding (LSE) China $0.089B 0.00
YHN Acquisition I (YHNA) $0.081B 0.00
Youxin Technology (YAAS) $0.065B 0.00
YSX Tech (YSXT) China $0.062B 0.00
New Century Logistics (BVI) (NCEW) Hong Kong, SAR China $0.026B 0.00
Sky Quarry (SKYQ) $0.016B 0.00
Flowco Holdings (FLOC) $0.000B 0.00